Murray McKinnon

1.6k total citations
35 papers, 902 citations indexed

About

Murray McKinnon is a scholar working on Molecular Biology, Immunology and Organic Chemistry. According to data from OpenAlex, Murray McKinnon has authored 35 papers receiving a total of 902 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 17 papers in Immunology and 9 papers in Organic Chemistry. Recurrent topics in Murray McKinnon's work include Melanoma and MAPK Pathways (10 papers), Computational Drug Discovery Methods (8 papers) and Asthma and respiratory diseases (7 papers). Murray McKinnon is often cited by papers focused on Melanoma and MAPK Pathways (10 papers), Computational Drug Discovery Methods (8 papers) and Asthma and respiratory diseases (7 papers). Murray McKinnon collaborates with scholars based in United States, United Kingdom and Germany. Murray McKinnon's co-authors include Peter J. Parker, John H. Dodd, Iain Uings, Michael D. Waterfield, Tsutomu Kodaki, Joel C. Barrish, Kim W. McIntyre, Malinda Longphre, Katerina Leftheris and Gary L. Schieven and has published in prestigious journals such as Science, Proceedings of the National Academy of Sciences and Journal of Biological Chemistry.

In The Last Decade

Murray McKinnon

34 papers receiving 881 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Murray McKinnon United States 17 469 284 177 117 112 35 902
Arsenio Nueda Spain 18 622 1.3× 229 0.8× 97 0.5× 109 0.9× 41 0.4× 29 959
Lu Min Wong United States 15 477 1.0× 183 0.6× 229 1.3× 276 2.4× 39 0.3× 21 1.0k
Wen‐Cherng Lee United States 15 627 1.3× 175 0.6× 132 0.7× 224 1.9× 47 0.4× 21 1000
Sascha Menninger Germany 11 929 2.0× 425 1.5× 227 1.3× 111 0.9× 67 0.6× 19 1.3k
Klaus Fuchs Germany 15 614 1.3× 143 0.5× 97 0.5× 122 1.0× 336 3.0× 22 1.2k
Y Uehara Japan 17 609 1.3× 190 0.7× 81 0.5× 212 1.8× 31 0.3× 23 889
Beth Apsel United States 7 1.1k 2.4× 161 0.6× 158 0.9× 181 1.5× 70 0.6× 7 1.5k
J.J. Keusch Switzerland 17 795 1.7× 228 0.8× 104 0.6× 171 1.5× 76 0.7× 22 1.1k
Matthias Stein-Gerlach Germany 11 624 1.3× 172 0.6× 62 0.4× 183 1.6× 41 0.4× 12 874
Troii Hall United States 14 625 1.3× 182 0.6× 44 0.2× 207 1.8× 51 0.5× 24 943

Countries citing papers authored by Murray McKinnon

Since Specialization
Citations

This map shows the geographic impact of Murray McKinnon's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Murray McKinnon with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Murray McKinnon more than expected).

Fields of papers citing papers by Murray McKinnon

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Murray McKinnon. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Murray McKinnon. The network helps show where Murray McKinnon may publish in the future.

Co-authorship network of co-authors of Murray McKinnon

This figure shows the co-authorship network connecting the top 25 collaborators of Murray McKinnon. A scholar is included among the top collaborators of Murray McKinnon based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Murray McKinnon. Murray McKinnon is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Braun, Asolina, Jesse I. Mobbs, Sushma Anand, et al.. (2025). A transgenic mouse allows characterization of the HLA-C∗06:02 immunopeptidome in a model of psoriasis. Journal of Investigative Dermatology.
2.
Wrobleski, Stephen T., Shuqun Lin, T. G. Murali Dhar, et al.. (2013). The identification of novel p38α isoform selective kinase inhibitors having an unprecedented p38α binding mode. Bioorganic & Medicinal Chemistry Letters. 23(14). 4120–4126. 15 indexed citations
3.
Liu, Chunjian, James C. Lin, Christoph Gesenberg, et al.. (2013). Synthesis and evaluation of carbamoylmethylene linked prodrugs of BMS-582949, a clinical p38α inhibitor. Bioorganic & Medicinal Chemistry Letters. 23(10). 3028–3033. 8 indexed citations
4.
Dyckman, Alaric J., Tianle Li, Sidney Pitt, et al.. (2011). Discovery of pyrrolo[2,1-f][1,2,4]triazine C6-ketones as potent, orally active p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 21(15). 4633–4637. 9 indexed citations
5.
Suchard, Suzanne J., Dawn K. Stetsko, Patricia M. Davis, et al.. (2010). An LFA-1 (αLβ2) Small-Molecule Antagonist Reduces Inflammation and Joint Destruction in Murine Models of Arthritis. The Journal of Immunology. 184(7). 3917–3926. 30 indexed citations
6.
Zhao, Qihong, Jian Pang, Kim W. McIntyre, et al.. (2009). A CCR2/CCR5-dual antagonist, BMS-A, offers a potential novel oral therapy for the treatment of autoimmune disease (92.6). The Journal of Immunology. 182(Supplement_1). 92.6–92.6. 2 indexed citations
7.
Kempson, James, Junqing Guo, Jagabandhu Das, et al.. (2009). Synthesis, initial SAR and biological evaluation of 1,6-dihydroimidazo[4,5-d]pyrrolo[2,3-b]pyridin-4-amine derived inhibitors of IκB kinase. Bioorganic & Medicinal Chemistry Letters. 19(10). 2646–2649. 16 indexed citations
8.
Wrobleski, Stephen T., Shuqun Lin, John Hynes, et al.. (2008). Synthesis and SAR of new pyrrolo[2,1-f][1,2,4]triazines as potent p38α MAP kinase inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2739–2744. 25 indexed citations
9.
Liu, Chunjian, James C. Lin, Sidney Pitt, et al.. (2008). Benzothiazole based inhibitors of p38α MAP kinase. Bioorganic & Medicinal Chemistry Letters. 18(6). 1874–1879. 47 indexed citations
10.
Das, Jagabandhu, Robert V. Moquin, Sidney Pitt, et al.. (2008). Pyrazolo-pyrimidines: A novel heterocyclic scaffold for potent and selective p38α inhibitors. Bioorganic & Medicinal Chemistry Letters. 18(8). 2652–2657. 37 indexed citations
11.
Dodd, Dharmpal S., S. Sheriff, ChiehYing Chang, et al.. (2007). Design of LFA-1 antagonists based on a 2,3-dihydro-1H-pyrrolizin-5(7aH)-one scaffold. Bioorganic & Medicinal Chemistry Letters. 17(7). 1908–1911. 11 indexed citations
12.
Yang, Xianbin, Dann L. Parker, Lewis Whitehead, et al.. (2006). A Collaborative Hit-to-Lead Investigation Leveraging Medicinal Chemistry Expertise with High Throughput Library Design, Synthesis and Purification Capabilities. Combinatorial Chemistry & High Throughput Screening. 9(2). 123–130. 6 indexed citations
13.
McIntyre, Kim W., Henry Shen, William J. Pitts, et al.. (2003). Phosphodiesterase 7A-Deficient Mice Have Functional T Cells. The Journal of Immunology. 171(12). 6414–6420. 79 indexed citations
14.
Miller, Laura M., W. Michael Foster, Donna M. Dambach, et al.. (2002). A MURINE MODEL OF CIGARETTE SMOKE-INDUCED PULMONARY INFLAMMATION USING INTRANASALLY ADMINISTERED SMOKE-CONDITIONED MEDIUM. Experimental Lung Research. 28(6). 435–455. 41 indexed citations
15.
Whitney, Gena S., Shulin Wang, Chang Han, et al.. (2001). A new siglec family member, siglec‐10, is expressed in cells of the immune system and has signaling properties similar to CD33. European Journal of Biochemistry. 268(23). 6083–6096. 80 indexed citations
16.
Proudfoot, Amanda E. I., Steven Brown, Pierre Graber, et al.. (1996). The carboxy-terminal region of human interleukin-5 is essential for maintenance of tertiary structure but not for dimerization. Journal of Protein Chemistry. 15(5). 491–499. 2 indexed citations
17.
Graber, Pierre, Amanda E. I. Proudfoot, Alain Bernard, et al.. (1995). Identification of Key Charged Residues of Human Interleukin-5 in Receptor Binding and Cellular Activation. Journal of Biological Chemistry. 270(26). 15762–15769. 49 indexed citations
18.
Banks, Martyn, Pierre Graber, Amanda E. I. Proudfoot, et al.. (1995). Soluble Interleukin-5 Receptor α-Chain Binding Assays: Use for Screening and Analysis of Interleukin-5 Mutants. Analytical Biochemistry. 230(2). 321–328. 15 indexed citations
19.
Kodaki, Tsutomu, et al.. (1994). A comparison of demethoxyviridin and wortmannin as inhibitors of phosphatidylinositol 3‐kinase. FEBS Letters. 342(2). 109–114. 107 indexed citations
20.
McKinnon, Murray & Peter J. Parker. (1994). Phospholipase-D activation can be negatively regulated through the action of protein kinase C. Biochimica et Biophysica Acta (BBA) - Molecular Cell Research. 1222(1). 109–112. 8 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Arsenio Nueda Breakdown of academic impact, for papers by Lu Min Wong Breakdown of academic impact, for papers by Wen‐Cherng Lee Breakdown of academic impact, for papers by Sascha Menninger Breakdown of academic impact, for papers by Klaus Fuchs Breakdown of academic impact, for papers by Y Uehara Breakdown of academic impact, for papers by Beth Apsel Breakdown of academic impact, for papers by J.J. Keusch Breakdown of academic impact, for papers by Matthias Stein-Gerlach Breakdown of academic impact, for papers by Troii Hall
Rankless by CCL
2026